Slide 1: First Quarter 2025 Results
ibdroot\projects\IBD-NY\vitus2024\938510_1\03. Roadshow Presentation\V2X - Roadshow Presentation (Nov- 2024)_vF.pptx First Quarter 2025 Results MISSION ENABLEMENT l END-TO-END CAPABILITIES l GLOBAL REACH May 5, 2025 GO TOWARDS TOMORROW #goV2X GO TOWARDS TOMORROW #goV2X
Slide 2: Disclaimers
ibdroot\projects\IBD-NY\vitus2024\938510_1\03. Roadshow Presentation\V2X - Roadshow Presentation (Nov- Disclaimers 2024)_vF.pptx FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the
Slide 3: Q1'25 & Recent Highlights
ibdroot\projects\IBD-NY\vitus2024\938510_1\03. Roadshow Presentation\V2X - Roadshow Presentation (Nov- Q1’25 & Recent Highlights 2024)_vF.pptx $1.02B • Revenue of $1.02B; +10% y/y growth in Indo-Pacific region • Increased revenue visibility & resilient business model Q1’25 Revenue • Notable new busi
Slide 4: Demonstrating the V2X Value Proposition
ibdroot\projects\IBD-NY\vitus2024\938510_1\03. Roadshow Presentation\V2X - Roadshow Presentation (Nov- Demonstrating the V2X Value Proposition 2024)_vF.pptx Platform Modernization High Impact Readiness Mission Solutions Space Force Army Space Force COBRA DANE: BEST MAC: Ascension Island: Awarded $62
Slide 5: Well Positioned for Today & Beyond
ibdroot\projects\IBD-NY\vitus2024\938510_1\03. Roadshow Presentation\V2X - Roadshow Presentation (Nov- Well Positioned for Today & Beyond 2024)_vF.pptx Backlog ($B) Revenue Visibility $2.2 ~5 yrs Of weighted duration on ~ 12B top 5 revenue programs $ ~3x Revenue Coverage in $9.7 Backlog Funded Unfun
Slide 6: Leveraging Strong Visibility for Growth
ibdroot\projects\IBD-NY\vitus2024\938510_1\03. Roadshow Presentation\V2X - Roadshow Presentation (Nov- Leveraging Strong Visibility for Growth 2024)_vF.pptx +50% ≥$1B 2029+ Expected year-over-year Planning submissions on 5 Top 5 programs extend increase in bid volume opportunities valued at ≥$1B in
Slide 7: Q1'25 Financial Results
ibdroot\projects\IBD-NY\vitus2024\938510_1\03. Roadshow Presentation\V2X - Roadshow Presentation (Nov- Q1’25 Financial Results 2024)_vF.pptx Revenue ($M) Adj. EBITDA1 ($M) $1,011 $1,016 $69 $67 Q1'24 Q1'25 Q1'24 Q1'25 Adj. EPS1 Adj. OCF 1 ($M) $(84) $(118) $0.98 $0.90 Q1'24 Q1'25 Q1'24 Q1'25 1 See a
Slide 8: Strong Liquidity & Enhanced Capital Structure
ibdroot\projects\IBD-NY\vitus2024\938510_1\03. Roadshow Presentation\V2X - Roadshow Presentation (Nov- Strong Liquidity & Enhanced Capital Structure 2024)_vF.pptx • Successfully repriced and extended Term Loan A and Revolving Credit Facility – Extended maturity to March 2030 – Updated pricing, offer
Slide 9: Reaffirming 2025 Guidance
ibdroot\projects\IBD-NY\vitus2024\938510_1\03. Roadshow Presentation\V2X - Roadshow Presentation (Nov- Reaffirming 2025 Guidance 2024)_vF.pptx 2025 2025 ($M, except per share data) Guidance Mid-Point Revenue $4,375 - $4,500 $4,438 Adjusted EBITDA1 $305 - $320 $313 Adjusted Earnings Per Share1 $4.45-
Slide 10: V2X Value Proposition
ibdroot\projects\IBD-NY\vitus2024\938510_1\03. Roadshow Presentation\V2X - Roadshow Presentation (Nov- V2X Value Proposition 2024)_vF.pptx 1 Well-Aligned with U.S. DoD Priorities in Strong End Markets 2 Long-Standing Relationships with Diverse Customers and Contract Base 3 Contract Backlog Provides
Slide 11: Appendix
ibdroot\projects\IBD-NY\vitus2024\938510_1\03. Roadshow Presentation\V2X - Roadshow Presentation (Nov- 2024)_vF.pptx Appendix GO TOWARDS TOMORROW #goV2X GO TOWARDS TOMORROW #goV2X
Slide 12: Key Performance Indicators and Non-GAAP Measures
ibdroot\projects\IBD-NY\vitus2024\938510_1\03. Roadshow Presentation\V2X - Roadshow Presentation (Nov- Key Performance Indicators and Non-GAAP 2024)_vF.pptx Measures This presentation includes certain non-GAAP financial measures, including adjusted net income, adjusted diluted earnings per share, ad
Slide 13: Reconciliation Of Non-GAAP Measures
ibdroot\projects\IBD-NY\vitus2024\938510_1\03. Roadshow Presentation\V2X - Roadshow Presentation (Nov- Reconciliation Of Non-GAAP Measures 2024)_vF.pptx ($K, except per share data) Three Months Ended March 28, 2025 March 29, 2024 Revenue $ 1,015,923 $ 1,010,564 Net income (loss) $ 8,107 $ 1,144 Plus
Slide 14: Reconciliation Of Non-GAAP Measures
ibdroot\projects\IBD-NY\vitus2024\938510_1\03. Roadshow Presentation\V2X - Roadshow Presentation (Nov- Reconciliation Of Non-GAAP Measures 2024)_vF.pptx ($K) Three Months Ended March 28, 2025 March 29, 2024 Net cash used by operating activities (95,464) (57,226) Plus: M&A, integration, and related p
Slide 15: Reconciliation Of Non-GAAP Measures
ibdroot\projects\IBD-NY\vitus2024\938510_1\03. Roadshow Presentation\V2X - Roadshow Presentation (Nov- Reconciliation Of Non-GAAP Measures 2024)_vF.pptx ($K) TTM March 28, 2025 Net income (loss) $ 41,647 Plus: Interest expense, net 100,045 Income tax expense 6,140 Depreciation and amortization 114,1
Slide 16: GO TOWARDS TOMORROW #goV2X
ibdroot\projects\IBD-NY\vitus2024\938510_1\03. Roadshow Presentation\V2X - Roadshow Presentation (Nov- 2024)_vF.pptx 1875 Campus Commons Drive www.goV2X.com Suite 305 Reston, VA 20191 GO TOWARDS TOMORROW 571.481.2000 PHONE GO V2X CONFIDENTIAL AND PROPRIETARY — COMPETITION SENSITIVE GO TOWARDS TOMORR